5-day vinblastine infusion for pancreatic adenocarcinoma. A phase II Southwest Oncology Group study. 1990

J T Guy, and T Fleming, and T W Pollock, and S E Rivkin, and R P Pugh, and H Saiers, and H E Hynes, and J F Boyd
Southwest Oncology Group Statistical Center, Seattle.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008297 Male Males
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000380 Agranulocytosis A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS). Granulocytopenia,Agranulocytoses,Granulocytopenias
D014747 Vinblastine Antitumor alkaloid isolated from Vinca rosea. (Merck, 11th ed.) Vincaleukoblastine,Cellblastin,Lemblastine,Velban,Velbe,Vinblastin Hexal,Vinblastina Lilly,Vinblastine Sulfate,Vinblastinsulfat-Gry,Sulfate, Vinblastine

Related Publications

J T Guy, and T Fleming, and T W Pollock, and S E Rivkin, and R P Pugh, and H Saiers, and H E Hynes, and J F Boyd
June 1984, Cancer treatment reports,
J T Guy, and T Fleming, and T W Pollock, and S E Rivkin, and R P Pugh, and H Saiers, and H E Hynes, and J F Boyd
September 1988, Investigational new drugs,
J T Guy, and T Fleming, and T W Pollock, and S E Rivkin, and R P Pugh, and H Saiers, and H E Hynes, and J F Boyd
March 1990, European journal of cancer (Oxford, England : 1990),
J T Guy, and T Fleming, and T W Pollock, and S E Rivkin, and R P Pugh, and H Saiers, and H E Hynes, and J F Boyd
February 1990, Investigational new drugs,
J T Guy, and T Fleming, and T W Pollock, and S E Rivkin, and R P Pugh, and H Saiers, and H E Hynes, and J F Boyd
January 1993, Cancer,
J T Guy, and T Fleming, and T W Pollock, and S E Rivkin, and R P Pugh, and H Saiers, and H E Hynes, and J F Boyd
February 1991, Investigational new drugs,
J T Guy, and T Fleming, and T W Pollock, and S E Rivkin, and R P Pugh, and H Saiers, and H E Hynes, and J F Boyd
April 1986, Cancer treatment reports,
J T Guy, and T Fleming, and T W Pollock, and S E Rivkin, and R P Pugh, and H Saiers, and H E Hynes, and J F Boyd
August 2004, Investigational new drugs,
J T Guy, and T Fleming, and T W Pollock, and S E Rivkin, and R P Pugh, and H Saiers, and H E Hynes, and J F Boyd
January 1997, Investigational new drugs,
J T Guy, and T Fleming, and T W Pollock, and S E Rivkin, and R P Pugh, and H Saiers, and H E Hynes, and J F Boyd
November 1984, Cancer treatment reports,
Copied contents to your clipboard!